BEXATAMIG
UNII 4NPQ7H99U6
Substance Identification & Data
This profile provides standardized clinical and technical data for Bexatamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4NPQ7H99U6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2871775-98-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
4NPQ7H99U6
2871775-98-1
N/A
Detailed Substance Profile
Preferred Name
BEXATAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13042
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
MN-177
Identifier assigned by the United States Adopted Names Council.
Substance Type
Bexatamig
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Bexatamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
Bexatamig
Common Names & Synonyms
BEXATAMIG [USAN]
Immunoglobulin G1 [55-serine,217-arginine,359-glutamic acid,361-methionine,de-450-lysine], anti-(human interleukin 3 receptor subunit α) (human-Mus musculus monoclonal 7G3 γ1-chain) fusion protein with peptide linker (STGS) fusion protein with immunoglobulin G1 anti-(human natural cytotoxicity triggering receptor 1) (human-Mus musculus monoclonal 3D9 γ1-chain VH-CH1 fragment), (223→220′),(229→226′),(232→229′)-tris(disulfide) with immunoglobulin [31-serine] anti-(human interleukin 3 receptor subunit α) (human-Mus musculus monoclonal 7G3 κ-chain) fusion protein with immunoglobulin G1 (human γ1-chain CH2-CH3 fragment), disulfide with human monoclonal 3D9 κ-chain
bexatamig [INN]
immunoglobulin (H-gamma1-VH-G1CH1h_L-kappa)_L-kappa- G1hCH2CH3, anti-[Homo sapiens IL3RA (interleukin 3 receptor subunit alpha, interleukin 3 receptor alpha (low affinity), CD123)] and anti-[Homo sapiens NCR1 (natural cytotoxicity triggering receptor 1, NKP46, NKp46, NK cell-activating receptor, LY94, CD335)], humanized monoclonal antibody, bispecific; [H-gamma1-VH-G1CH1h chain anti-IL3RA and anti-NCR1 humanized (1-681) [H-gamma1 anti-IL3RA [VH (Homo sapiens IGHV5-10-1*04 (82.7%) -(IGHD) -IGHJ6*01 (90.9%) T123>M (115), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03 (100%), G1m3, nG1m1 CH1 R120, CH3 E12, M14 (CH1 R120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 (344-448), CHS K2>del (449) (121-449))] -4- mer-seryl-threonyl-glycyl-seryl linker (450-453) -VH-G1CH1h anti-NCR1 humanized (454-681) [VH (Homo sapiens IGHV1- 69*08 (83.7%) -(IGHD) -IGHJ4*01 (92.3%) L123>T (568), CDR- IMGT [8.8.13] (479-486.504-511.550-562)) (454-573) -IGHG1*03 CH1-h (100%), G1m3 CH1 R120 (CH1 R120 (670) (574-671), hinge 1-10 (672-681)) (574-681)]; (676-214')-disulfide with L-kappa light chain anti-NCR1 humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-33*01 (88.4%) -IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27'-32'.50'- 52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153'), V101 (191') (108'-214')]; (223-220'':229-226'':232-229'')-trisdisulfide with the L-kappa- G1hCH2CH3 chain anti-IL3RA humanized (1-447'') [L-kappa anti-IL3RA (1''-220'') [V-KAPPA (Homo sapiens IGKV4-1*01 (90.1%) -IGKJ2*01 (100%), CDR-IMGT [12.3.9] (27''-38''.56''- 58''.95''-103'')) (1''-113'') -Homo sapiens IGKC*01 (100%), Km3 A45.1 A45.1 (159''), V101 (197'') (114''-220'')] -G1hCH2CH3 (221''-447'') [Homo sapiens IGHG1*03 h-CH2-CH3-CHS (100%), nG1m1 CH3 E12, M14 (hinge 6-15 (221''-230''), CH2 (231''- 340''), CH3 E12 (356''), M14 (358'') (341''-445''), CHS (446''- 447''))]], produced in a cell line from Chinese hamster ovary (CHO) cells, derived from the cell line CHO-DXB11, glycoform alfa
Technical Codes
SAR-443579
SAR443579
